Transthyretin cardiac amyloidosis

Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart failure (HF) and mortality worldwide. Advances in non-invasive diagnosis, coupled with the development of effective treatments, have shifted ATTR-CA from a rare and untreatable disease to a relatively prevalent...

Descripción completa

Detalles Bibliográficos
Autores principales: Porcari, Aldostefano, Fontana, Marianna, Gillmore, Julian D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Spotlight Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897687/
https://www.ncbi.nlm.nih.gov/pubmed/35929637
http://dx.doi.org/10.1093/cvr/cvac119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897687/
https://www.ncbi.nlm.nih.gov/pubmed/35929637
http://dx.doi.org/10.1093/cvr/cvac119

Ejemplares similares